Obesity prevalence in low-income preschool children in Oklahoma

Ashley E Weedn1, Siew C Ang, Carrie L Zeman

  • 1University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Ashley-Weedn@ouhsc.edu

Clinical Pediatrics
|April 24, 2012
PubMed

Insights

Obesity affects 30.7% of low-income Oklahoma preschoolers. American Indian and Hispanic children show higher obesity rates, indicating a need for targeted interventions.

Area of Science:

  • Pediatric Nutrition
  • Public Health
  • Health Disparities

Background:

  • Childhood obesity is a significant public health concern.
  • Low-income preschool children are particularly vulnerable to nutritional challenges.
  • Understanding race/ethnic disparities in obesity is crucial for effective interventions.

Purpose of the Study:

  • To determine the prevalence of overweight and obesity in low-income preschool children in Oklahoma.
  • To identify potential race/ethnic disparities in obesity rates among these children.

Main Methods:

  • Utilized data from 39,151 children aged 2-4 years enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) in Oklahoma during 2009.
  • Calculated body mass index (BMI) percentiles using child's height, weight, sex, and age.

Main Results:

  • In 2009, 30.7% of Oklahoma WIC children were overweight, with 13.7% classified as obese.
  • Significant race/ethnic disparities were observed, particularly for obesity: American Indian (18.8%) and Hispanic (17.2%) children had higher prevalence compared to non-Hispanic whites (11.8%).
  • African American children showed lower obesity prevalence (OR = 0.9).

Conclusions:

  • Obesity rates are disproportionately high among American Indian and Hispanic low-income preschool children in Oklahoma.
  • Interventions specifically targeting these high-risk racial/ethnic groups are warranted to address these disparities.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...